213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience
暂无分享,去创建一个
U. Haberkorn | F. Giesel | C. Kratochwil | C. Apostolidis | F. Bruchertseifer | W. Mier | R. Boll | A. Morgenstern | K. Murphy